| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Director
4 companies
Goldstein Dov A Md is a Director at Coya Therapeutics, Inc. with holdings across 4 companies. Recent SEC Form 4 filings include 1 buy and 9 sells.
Estimated insider holdings value: $667K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 13, 2026 | BIOA Bioage Labs, Inc. | Chief Financial Officer | Sale+OE | 27,000 | $19.70 | $531,827.69 | -18.0% | -21.7% | - | |
| Jan 3, 2023 | COYA Coya Therapeutics, Inc. | Director | Buy | 10,000 | $0.00 | - | New | -12.9% | +48.2% | |
| Mar 22, 2017 | ESPR Esperion Therapeutics, Inc. | Director | Sell | 800,000 | $41.66 | $33,327,088.28 | -28.7% | - | - | |
| Apr 24, 2015 | ESPR Esperion Therapeutics, Inc. | Director | Sell | 217,469 | $108.22 | $23,534,372.60 | -3.7% | - | - |